��������

Murali Krishna Amathi is an experienced analytical development professional with a comprehensive background in pharmaceutical research and development, currently serving as Associate Director at Innoviva Specialty Therapeutics, Inc. since January 2024. Previously, Murali held the position of Senior Manager in Analytical Development and Quality Control at Relay Therapeutics, where expertise was demonstrated in managing technical transfers and authoring CMC modules for regulatory submissions. Additional experience includes roles at Hikma Pharmaceuticals as Principal Scientist, overseeing analytical R&D and supporting ANDA and NDA submissions for anticancer formulations, and as Analytical R&D and Product Development Manager at Invatech, managing departmental operations and budget planning. Murali's career encompasses significant contributions in stability studies, formulation development, and regulatory support across various esteemed organizations, complemented by a Master's degree in Analytical Chemistry and a degree in Pharmacy.